AI Portfolio Summary
In 2026 Q1, GENERAL ATLANTIC, L.P. maintained a portfolio of 13 distinct positions. They heavily accumulated shares in ALKAMI, increasing their position by 27.9%. Conversely, GENERAL ATLANTIC, L.P. completely exited their position in ALIGNMENT HEALTHCARE.
Total Positions
13
Quarter
2026 Q1
Top Holding
DLO (28.2%)
Top 10 Concentration
99.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-13 of 13
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DLO
DLOCAL
|
Technology | 28.17% | 22.97% |
#1
Prev: #1
|
7.0 | no change | no change |
P
S
|
46,656,695 | $605,137,334 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CHYM
CHIME
|
Technology | 18.53% | 18.63% |
#2
Prev: #2
|
6.5 | no change | no change |
P
S
|
21,259,683 | $398,193,863 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
XP
XP, INC
|
Financial Services | 18.23% | 12.93% |
#3
Prev: #3
|
5.5 | -2,133,000 | -9.4% |
P
S
|
20,566,133 | $391,579,172 | 2019 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALKT
ALKAMI
|
Technology | 11.19% | 9.63% |
#4
Prev: #4
|
7.0 | 3,346,015 | 27.9% |
P
S
|
15,337,495 | $240,338,547 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
PHVS
PHARVARIS
|
Healthcare | 10.56% | 7.76% |
#5
2
Prev: #7
|
5.5 | no change | no change |
P
S
|
8,031,252 | $226,882,869 | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
EWCZ
EUROPEAN WAX CE...
|
Consumer Defensive | 3.53% | 1.64% |
#6
4
Prev: #10
|
2.4 | no change | no change |
P
S
|
13,110,492 | $75,778,644 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 3.20% | 7.80% |
#7
1
Prev: #6
|
1.3 | -2,105,137 | -74.8% |
P
S
|
707,791 | $68,832,675 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
NRIX
NURIX THERAPEUT...
|
Healthcare | 2.96% | 3.23% |
#8
1
Prev: #9
|
1.7 | -795,294 | -16.2% |
P
S
|
4,101,865 | $63,578,908 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
CNTA
CENTESSA PHARMA...
|
Healthcare | 2.50% | 5.33% |
#9
1
Prev: #8
|
1.0 | -4,762,885 | -77.9% |
P
S
|
1,354,830 | $53,813,848 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RSKD
RISKIFIED
|
Technology | 0.97% | 0.92% |
#10
1
Prev: #11
|
1.4 | no change | no change |
P
S
|
5,324,998 | $20,873,992 | 2021 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GROV
GROVE COLLABORA...
|
Consumer Defensive | 0.15% | 0.09% |
#11
1
Prev: #12
|
1.1 | no change | no change |
P
S
|
2,474,859 | $3,167,820 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BULL
WEBULL
|
Technology | 0.01% | 0.01% |
#12
1
Prev: #13
|
1.0 | no change | no change |
P
S
|
50,816 | $243,917 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ALHC
ALIGNMENT HEALT...
|
Healthcare | 0.00% | 9.05% |
Sold All 😨
(Was: #5) |
0.0 | -13,167,733 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-13 of 13 holdings